{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:01:46Z","timestamp":1790517706805,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.phrs.2013.07.007","type":"journal-article","created":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T16:31:16Z","timestamp":1375461076000},"page":"67-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress"],"prefix":"10.1016","volume":"76","author":[{"given":"Giuseppina","family":"Mattace Raso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Simeoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"d\u2019Emmanuele di Villa Bianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Mitidieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Paciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Bruna","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Salvatore","family":"Orefice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Meli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2013.07.007_bib0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0021-9258(18)97531-9","article-title":"Fatty acid amides of ethanolamine in mammalian tissues","volume":"240","author":"Bachur","year":"1965","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.phrs.2013.07.007_bib0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/sj.bjp.0704466","article-title":"Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat","volume":"135","author":"Conti","year":"2002","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","article-title":"Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide","volume":"419","author":"Calignano","year":"2001","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.106.111385","article-title":"Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha","volume":"319","author":"LoVerme","year":"2006","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.phrs.2013.07.007_bib0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/jpet.107.123265","article-title":"Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice","volume":"322","author":"D\u2019Agostino","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.phrs.2013.07.007_bib0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.04.022","article-title":"Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia","volume":"613","author":"D\u2019Agostino","year":"2009","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0040","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.bbalip.2007.04.021","article-title":"PPARalpha in atherosclerosis and inflammation","volume":"1771","author":"Zandbergen","year":"2007","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.phrs.2013.07.007_bib0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pain.2011.08.010","article-title":"Implication of allopregnanolone in the antinociceptive effect of N-palmitoylethanolamide in acute or persistent pain","volume":"153","author":"Sasso","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2013.07.007_bib0050","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2826.2011.02152.x","article-title":"Palmitoylethanolamide stimulation induces allopregnanolone synthesis in C6 Cells and primary astrocytes: involvement of peroxisome-proliferator activated receptor-\u03b1","volume":"23","author":"Mattace Raso","year":"2011","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0055","series-title":"The metabolic syndrome at the beginning of the 21st century","first-page":"264","article-title":"Role of PPARs in the pathogenesis of the metabolic syndrome","author":"Medina-Gomez","year":"2005"},{"key":"10.1016\/j.phrs.2013.07.007_bib0060","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1523-1755.2001.00766.x","article-title":"Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease","volume":"60","author":"Guan","year":"2001","journal-title":"Kidney International"},{"key":"10.1016\/j.phrs.2013.07.007_bib0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/jpet.110.171090","article-title":"Peroxisome proliferator-activated receptor {alpha} agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats","volume":"335","author":"Gelosa","year":"2010","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.phrs.2013.07.007_bib0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/hr.2009.107","article-title":"Peroxisome proliferator-activated receptor-alpha activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats","volume":"32","author":"Shin","year":"2009","journal-title":"Hypertension Research"},{"key":"10.1016\/j.phrs.2013.07.007_bib0080","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.HYP.0000153317.06072.2e","article-title":"Fenofibrate prevents the development of angiotensin II-dependent hypertension in mice","volume":"45","author":"Vera","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0085","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbrc.2010.03.043","article-title":"PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity","volume":"394","author":"Hou","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.phrs.2013.07.007_bib0090","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.HYP.0000037969.41360.CC","article-title":"PPAR\u03b1 activator effects on Ang II-induced vascular oxidative stress and inflammation","volume":"40","author":"Diep","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0095","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1210\/me.2002-0020","article-title":"Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter","volume":"16","author":"Girnun","year":"2002","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0100","doi-asserted-by":"crossref","first-page":"745804","DOI":"10.1155\/2008\/745804","article-title":"PPAR-\u03b3 in the cardiovascular system","volume":"2008","author":"Duan","year":"2008","journal-title":"PPAR Research"},{"key":"10.1016\/j.phrs.2013.07.007_bib0105","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00004872-200104000-00012","article-title":"Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia","volume":"19","author":"Jonkers","year":"2001","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0110","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.ki.5001620","article-title":"Protection of the kidney by thiazolidinediones: an assessment from bench to bedside","volume":"70","author":"Sarafidis","year":"2006","journal-title":"Kidney International"},{"key":"10.1016\/j.phrs.2013.07.007_bib0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1677\/JOE-07-0159","article-title":"Maternal adaptations to pregnancy in spontaneously hypertensive rats: leptin and ghrelin evaluation","volume":"194","author":"Mattace Raso","year":"2007","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0120","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1046\/j.1471-4159.1994.63051855.x","article-title":"Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption","volume":"63","author":"Montoliu","year":"1994","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.phrs.2013.07.007_bib0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.1988.tb38534.x","article-title":"Activated neutrophils release mediators that may contribute to myocardial injury and dysfunction associated with ischemia and reperfusion","volume":"524","author":"Mullane","year":"1988","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.phrs.2013.07.007_bib0130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.phrs.2013.07.007_bib0135","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.phrs.2013.07.007_bib0140","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/HJH.0b013e328352b89a","article-title":"Development of structural kidney damage in spontaneously hypertensive rats","volume":"30","author":"Hultstrom","year":"2012","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0145","first-page":"F372","article-title":"Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats","volume":"259","author":"Chatziantoniou","year":"1990","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0150","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(25)09561-8","article-title":"Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats","volume":"273","author":"Vyas","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.phrs.2013.07.007_bib0155","first-page":"S92","article-title":"Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension","volume":"30","author":"Arendshorst","year":"1990","journal-title":"Kidney International Supplements"},{"key":"10.1016\/j.phrs.2013.07.007_bib0160","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000066792","article-title":"Renal hemodynamics during development of hypertension in young spontaneously hypertensive rats","volume":"25","author":"Christiansen","year":"2002","journal-title":"Kidney and Blood Pressure Research"},{"key":"10.1016\/j.phrs.2013.07.007_bib0165","first-page":"F591","article-title":"Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR","volume":"262","author":"Omata","year":"1992","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.HYP.22.3.357","article-title":"Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450","volume":"22","author":"Imig","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0175","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1124\/mol.52.3.362","article-title":"Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney","volume":"52","author":"Kroetz","year":"1997","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0180","doi-asserted-by":"crossref","first-page":"R255","DOI":"10.1152\/ajpregu.2001.280.1.R255","article-title":"CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR","volume":"280","author":"Wang","year":"2001","journal-title":"American Journal of Physiology \u2013 Regulatory, Integrative and Comparative Physiology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1620\/tjem.166.85","article-title":"Effect of acute and chronic treatment of tin on blood pressure in spontaneously hypertensive rats","volume":"166","author":"Laniado-Schwartzman","year":"1992","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"10.1016\/j.phrs.2013.07.007_bib0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1139\/y99-149","article-title":"Fenofibrate lowers blood pressure in two genetic models of hypertension","volume":"78","author":"Shatara","year":"2000","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0195","doi-asserted-by":"crossref","first-page":"H2455","DOI":"10.1152\/ajpheart.00512.2008","article-title":"Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats","volume":"295","author":"Dunn","year":"2008","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"Imig","year":"2009","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.phrs.2013.07.007_bib0205","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.HYP.0000176237.74820.75","article-title":"An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension","volume":"46","author":"Imig","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0210","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2174\/1389200043335603","article-title":"Role of cytochrome p450 metabolites of arachidonic acid in hypertension","volume":"5","author":"Sarkis","year":"2004","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/j.phrs.2013.07.007_bib0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/01.HYP.0000032100.23772.98","article-title":"Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II","volume":"40","author":"Landmesser","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0220","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ajh.2009.68","article-title":"Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney","volume":"22","author":"Iacono","year":"2009","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0225","first-page":"153","article-title":"Mitogen-activated protein kinase pathways: regulation and physiological functions","volume":"22","author":"Pearson","year":"2001","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.phrs.2013.07.007_bib0230","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(03)01538-3","article-title":"A superoxide dismutase mimetic with catalase activity (EUK-8) reduces the organ injury in endotoxic shock","volume":"466","author":"McDonald","year":"2003","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0235","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/HYPERTENSIONAHA.107.102467","article-title":"Attenuation of Angiotensin II-mediated NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment","volume":"51","author":"Whaley-Connell","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0240","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","article-title":"Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells","volume":"74","author":"Griendling","year":"1994","journal-title":"Circulation Research"},{"key":"10.1016\/j.phrs.2013.07.007_bib0245","first-page":"729","article-title":"Effect of peroxisome proliferator-activated receptor \u03b1 on human angiotensinogen promoter","volume":"13","author":"Shimamoto","year":"2004","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.phrs.2013.07.007_bib0250","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1291\/hypres.30.1231","article-title":"Inhibition of vascular angiotensin-coverting enzyme by telmisartan via the peroxisome proliferator-activated receptor \u03b3 agonistic property in rats","volume":"30","author":"Takai","year":"2007","journal-title":"Hypertension Research"},{"key":"10.1016\/j.phrs.2013.07.007_bib0255","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/FJC.0b013e31826216ed","article-title":"Clofibrate PPAR\u03b1 activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia","volume":"60","author":"Ibarra-Lara","year":"2012","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0260","doi-asserted-by":"crossref","first-page":"23317","DOI":"10.1074\/jbc.271.38.23317","article-title":"p22phox is a critical component of the superoxide-generating NADH\/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells","volume":"271","author":"Ushio-Fukai","year":"1996","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.phrs.2013.07.007_bib0265","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1523-1755.2004.00539.x","article-title":"The intrarenal renin-angiotensin system in hypertension","volume":"65","author":"Navar","year":"2004","journal-title":"Kidney International"},{"key":"10.1016\/j.phrs.2013.07.007_bib0270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.0000100443.09293.4F","article-title":"Reactive oxygen species in the vasculature: molecular and cellular mechanisms","volume":"42","author":"Taniyama","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0275","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.RES.86.12.1266","article-title":"Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms","volume":"86","author":"Ruiz-Ortega","year":"2000","journal-title":"Circulation Research"},{"key":"10.1016\/j.phrs.2013.07.007_bib0280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"De Gasparo","year":"2000","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.phrs.2013.07.007_bib0285","first-page":"F10","article-title":"Young SHR express increased type I angiotensin II receptors in renal proximal tubule","volume":"274","author":"Hui-Fang","year":"1998","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0290","first-page":"F499","article-title":"Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats","volume":"300","author":"Landgraf","year":"2011","journal-title":"American Journal of Physiology"},{"key":"10.1016\/j.phrs.2013.07.007_bib0295","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/HYPERTENSIONAHA.110.164970","article-title":"Glucocorticoid-induced fetal programming alters the functional complement of angiotensin receptor subtypes within the kidney","volume":"57","author":"Gwathmey","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2013.07.007_bib0300","doi-asserted-by":"crossref","first-page":"207e10","DOI":"10.1254\/jjp.62.207","article-title":"Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents","volume":"62","author":"Okunishi","year":"1993","journal-title":"Japanese Journal of Pharmacology"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661813001229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661813001229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T13:38:38Z","timestamp":1746020318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661813001229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":60,"alternative-id":["S1043661813001229"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2013.07.007","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2013.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}